Inventor · disambiguated record
Kasturi Bedi
Also filed as: BEDI KASTURI L · BEDI KASTURI LAL
9 granted patents·14 pending applications·85 citations·filing 1993–2008
87Inventor score
Top patents by PatentIndex Score
23 records- 0183US7001619B2Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugsCOUNCIL SCIENT IND RES·Filed 2002·Granted Feb 21, 2006·25 cites·12 claims
- 0282US7514105B2Bioavailability/bioefficacy enhancing activity of Cuminum cyminum and extracts and fractions thereofCOUNCIL SCIENT IND RES·Filed 2006·Granted Apr 7, 2009·8 cites·2 claims
- 0377US7070814B2Bioavailability / bioefficacy enhancing activity of Cuminum cyminum and extracts and fractions thereofCOUNCIL SCIENT IND RES·Filed 2003·Granted Jul 4, 2006·13 cites·38 claims
- 0471US7119075B2Use of herbal agents for potentiation of bioefficacy of anti infectivesCOUNCIL SCIENT IND RES·Filed 2003·Granted Oct 10, 2006·4 cites·26 claims
- 0569US2008292736A1Bioavailability enhancing activity of carum carvi extracts and fractions thereofCOUNCIL SCIENT IND RES·Filed 2008·Application pending·0 cites
- 0664US2007020347A1Bioavailability enhancing activity of Carum carvi extracts and fractions thereofCOUNCIL SCIENT IND RES·Filed 2006·Application pending·0 cites
- 0764US2005214390A1Bioavailability enhancing activity of Carum carvi extracts and fractions thereofCOUNCIL SCIENT IND RES·Filed 2004·Application pending·0 cites
- 0864US2008138452A1Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugsJOHRI RAKESH KAMAL·Filed 2007·Application pending·0 cites
- 0960US6670459B2Process for the isolation of novel oligospirostanosideZANDU PHARMACEUTICAL WORKS LTD·Filed 2002·Granted Dec 30, 2003·6 cites·6 claims
- 1057US2003228381A1Bioavailability enhancing activity of Carum carvi extracts and fractions thereofCOUNCIL SCIENT IND RES·Filed 2003·Application pending·0 cites
- 1154US6649745B2Oligospirostanoside, pharmaceutical composition containing novel oligospirostanoside and method for immunomodulation using said oligospirostanosideCOUNCIL SCIENT IND RES·Filed 2002·Granted Nov 18, 2003·1 cites·6 claims
- 1253US2007275006A1Iridoid glycoside compositionCOUNCIL SCIENT IND RES·Filed 2007·Application pending·0 cites
- 1352US5439891AProcess for preparation of pharmaceutical composition with enhanced activity for treatment of tuberculosis and leprosyFiled 1993·Granted Aug 8, 1995·28 cites·4 claims
- 1450US2006257505A1Bioavailability enhancing activity of carum carvi extracts and fractions thereofCOUNCIL SCIENT IND RES·Filed 2006·Application pending·0 cites
- 1549US2006121138A1Hepatocurative effect of Emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugsJOHRI RAKESH K·Filed 2005·Application pending·0 cites
- 1647US6989162B2Hepatoprotective agent of plant origin and a process thereofCOUNCIL SCIENT IND RES·Filed 2003·Granted Jan 24, 2006·0 cites·14 claims
- 1746US2003170321A1Bioavailability enhancing activity of Carum carvi extracts and fractions thereofCOUNCIL SCIENT IND RES·Filed 2002·Application pending·0 cites
- 1846US2003170326A1Bioavailability enchancing activity of Zingiber officinale Linn and its extracts/fractions thereofCOUNCIL SCIENT IND RES·Filed 2002·Application pending·0 cites
- 1943US7259148B2Hepatoprotective activity of 2′-p-hydroxybenzoylmussaenosidic acidCOUNCIL SCIENT IND RES·Filed 2003·Granted Aug 21, 2007·0 cites·16 claims
- 2043US2003185911A1Herbal nutraceuticals and a process for preparing the sameFiled 2002·Application pending·0 cites
- 2139US2004121028A1Plant based agents as bioavailability / bioefficacy enhancers for drugs and nutraceuticalsCOUNCIL SCIENT IND RES·Filed 2003·Application pending·0 cites
- 2237US2003230478A1Process for the preparation of 1,4 - dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agentsCOUNCIL SCIENT IND RES·Filed 2003·Application pending·0 cites
- 2336US2004029816A1Hepatoprotective activity of 10-O-P-hydroxybenzoyiaucubinFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →